|
|
Volumn 23, Issue 5, 2002, Pages 231-232
|
|
Dendritic-cell-based anticancer vaccination: Has it matured?
a
a
KEIO UNIVERSITY
(Japan)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
CD40 LIGAND;
CHEMOKINE;
FLT3 LIGAND;
GAMMA INTERFERON;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERLEUKIN 12;
INTERLEUKIN 4;
ISCOM;
KEYHOLE LIMPET HEMOCYANIN;
OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;
PROSTATE SPECIFIC ANTIGEN;
ANTIGEN SPECIFICITY;
CANCER IMMUNOTHERAPY;
CELL MATURATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
CYTOTOXIC T LYMPHOCYTE;
DENDRITIC CELL;
DRUG EFFECT;
GENE DELIVERY SYSTEM;
HUMAN;
IMMUNOSTIMULATION;
LANGERHANS CELL;
LYMPHOCYTIC INFILTRATION;
REGULATORY MECHANISM;
SIDE EFFECT;
SKIN CELL;
TUMOR IMMUNITY;
TUMOR REGRESSION;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
CANCER VACCINES;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
DENDRITIC CELLS;
GENETIC VECTORS;
HUMANS;
MEMBRANE PROTEINS;
NEOPLASMS;
PROSTATE-SPECIFIC ANTIGEN;
VACCINATION;
|
|
EID: 0036570609
PISSN: 14714906
EISSN: None
Source Type: Journal
DOI: 10.1016/S1471-4906(02)02198-1 Document Type: Conference Paper |
|
Times cited : (12)
|
|
References (8)
|
